RIEDEL NORBERT G

CIK 00011616628 companiesDEERPARK, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001161662

Recent Transactions

50 trades

Award
Eton Pharmaceuticals, Inc.$ETON
Employee Stock Option (Right to Buy)
2026-01-12+12,196→ 286,496 total
Award
Eton Pharmaceuticals, Inc.$ETON
Restricted Stock Units
2026-01-12+7,757→ 294,253 total
Tax Payment
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2025-08-08$111.25/sh−1,805→ 7,024 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2025-08-07+3,507→ 8,829 total
Exercise/Conversion
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2025-01-03$3.78/sh+50,000→ 137,145 total
Exercise/Conversion
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2025-01-03$3.47/sh+25,000→ 162,145 total
Exercise/Conversion
Eton Pharmaceuticals, Inc.$ETON
Employee Stock Option (Right to Buy)
2025-01-03−25,000→ 0 total
Exercise/Conversion
Eton Pharmaceuticals, Inc.$ETON
Employee Stock Option (Right to Buy)
2025-01-03−50,000→ 0 total
Exercise/Conversion
Eton Pharmaceuticals, Inc.$ETON
Employee Stock Option (Right to Buy)
2025-01-03−27,400→ 0 total
Exercise/Conversion
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2025-01-03$3.58/sh+27,400→ 87,145 total
Award
Eton Pharmaceuticals, Inc.$ETON
Employee Stock Option (Right to Buy)
2025-01-03+25,000→ 25,000 total
Tax Payment
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2024-08-06$111.35/sh−1,484→ 5,322 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2024-08-02+3,731→ 6,806 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-08-01−46,092→ 10,461 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-08-01−10,461→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-08-01−95,242→ 0 total
Award
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-06-05+10,461→ 56,553 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option (Right to buy)
2024-02-13+30,000→ 164,555 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2023-08-14$138.16/sh−1,241→ 13,705 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2023-08-11+3,075→ 14,946 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2023-06-07+13,780→ 13,780 total
Award
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-06-07+3,282→ 46,092 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option (Right to buy)
2023-03-03+25,000→ 134,555 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2023-01-03+420,000→ 420,000 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2022-08-08$152.32/sh−1,089→ 11,871 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2022-08-05+2,561→ 12,960 total
Exercise/Conversion
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2022-08-05$55.28/sh+8,000→ 18,399 total
Exercise/Conversion
Jazz Pharmaceuticals plc$JAZZ
Non-Qualified Stock Option (right to buy)
2022-08-05−8,000→ 0 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2022-08-05$155.87/sh−8,000→ 10,399 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-06-14+23,459→ 23,459 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option (Right to buy)
2022-02-07+50,000→ 109,555 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2022-01-04+14,270→ 42,810 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2022-01-04−14,270→ 0 total
Purchase
Aptinyx Inc.
Common Stock
2021-12-06$2.23/sh+100,000→ 100,000 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2021-12-02+475,000→ 475,000 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2021-08-06$147.96/sh−1,306→ 10,399 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2021-07-29+2,246→ 11,705 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2021-06-10+58,003→ 58,003 total
Exercise/Conversion
Aptinyx Inc.
Restricted Stock Units
2021-05-17−380,000→ 0 total
Exercise/Conversion
Aptinyx Inc.
Common Stock
2021-05-17+380,000→ 742,539 total
Tax Payment
Aptinyx Inc.
Common Stock
2021-05-17$2.53/sh−127,274→ 615,265 total
Tax Payment
Aptinyx Inc.
Common Stock
2021-05-17$2.53/sh−127,274→ 615,265 total
Exercise/Conversion
Aptinyx Inc.
Restricted Stock Units
2021-05-17−380,000→ 0 total
Exercise/Conversion
Aptinyx Inc.
Common Stock
2021-05-17+380,000→ 742,539 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option (Right to buy)
2021-05-03+19,655→ 59,555 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2021-02-24+733,300→ 733,300 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2021-01-04−14,270→ 14,270 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2021-01-04+14,270→ 28,540 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2020-08-07$125.87/sh−931→ 9,459 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2020-08-06+2,705→ 10,390 total

Companies

Recent Filings

Address

C/O ETON PHARMACEUTICALS, INC. 21925 W. FIELD PARKWAY, SUITE 235

DEERPARK, IL, 60010-7208

View on SEC.gov